Clinical Trials

Clinical trials are essential to developing new treatments for the diseases that cause dementia, and to ensuring that these are safe and effective.

For people in the UK to be among the first to benefit from new treatments the UK needs to be a leading location for clinical trials. This is dependent on a number of factors including investment in research and the clinical trials infrastructure and how easy it is for pharmaceutical companies to conduct trials and for new treatments to be approved for use in the healthcare system.

The Future of Clinical Trials. ARUK report 2021.

Dementia Attitudes Monitor (Alzheimer’s Research UK).

Parliamentary question for DHSC on clinical trial recruitment.

The Future of Clinical Trials. ARUK report 2021.

Are we ready to deliver disease modifying treatments, ARUK report 2021.

National Audit of Dementia 2021.

The Future of Clinical Trials. Alzheimer’s Research UK Report 2021.

The number of people recruited to dementia clinical trials is far behind other major diseases